✦ LIBER ✦

CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

✍ Scribed by Viviane Hess; Bengt Glimelius; Philipp Grawe; Daniel Dietrich; György Bodoky; Thomas Ruhstaller; Emilio Bajetta; Piercarlo Saletti; Arie Figer; Werner Scheithauer; Richard Herrmann

Book ID: 117784593
Publisher: The Lancet
Year: 2008
Tongue: English
Weight: 186 KB
Volume: 9
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(08)70001-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estimating prognosis and palliation base

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

✍ Bernhard, J; Dietrich, D; Glimelius, B; Hess, V; Bodoky, G; Scheithauer, W; Herr 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 371 KB

CA 19-9 as a biomarker in advanced pancr

CA 19-9 as a biomarker in advanced pancreatic cancer patients randomised to gemcitabine plus axitinib or gemcitabine alone

✍ Wasan, H S; Springett, G M; Chodkiewicz, C; Wong, R; Maurel, J; Barone, C; Rosbr 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 196 KB

CA19-9 as a predictor of tumor response

CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy

✍ Nazik HAMMAD; Lance K HEILBRUN; Philip A PHILIP; Anthony F SHIELDS; Mark M ZALUP 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Cancer-associated tumour markers CA 19-9

Cancer-associated tumour markers CA 19-9 and CA-50 in patients with pancreatic cancer with special reference to the Lewis blood cell status

✍ Masson, P; Pålsson, B; Andrén-Sandberg, Å 📂 Article 📅 1990 🏛 Nature Publishing Group 🌐 English ⚖ 686 KB

The use of tumour markers CEA, CA-195 an

The use of tumour markers CEA, CA-195 and CA-242 in evaluating the response to chemotherapy in patients with advanced colorectal cancer

✍ Ward, U; Primrose, JN; Finan, PJ; Perren, TJ; Selby, P; Purves, DA; Cooper, EH 📂 Article 📅 1993 🏛 Nature Publishing Group 🌐 English ⚖ 751 KB

Carbohydrate antigen 19-9 is a prognosti

Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy : A pooled analysis of 6 prospective trials

✍ Todd M. Bauer; Bassel F. El-Rayes; Xiaobai Li; Nazik Hammad; Philip A. Philip; A 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 327 KB